Filtered By:
Specialty: Anesthesiology
Management: European Medicines Agency (EMA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Use and safety of aprotinin in routine clinical practice: A European postauthorisation safety study conducted in patients undergoing cardiac surgery
CONCLUSION
The data in the NApaR indicated that in this patient population, at high risk of death or blood loss undergoing cardiac surgery, including complex cardiac surgeries other than iCABG, the incidence of adverse events is in line with data from current literature, where aprotinin was not used.
TRIAL REGISTRATION
EU PAS register number: EUPAS11384.
Source: European Journal of Anaesthesiology - July 19, 2022 Category: Anesthesiology Tags: Cardiac surgery Source Type: research
